Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer

被引：0
|
作者：
Julia Foldi
Anastasia Tsagianni
Max Salganik
Catherine A. Schnabel
Adam Brufsky
G. J. van Londen
Lajos Pusztai
Tara Sanft
机构：
[1] Yale School of Medicine,Section of Medical Oncology
[2] University of Pittsburgh School of Medicine,Division of Hematology and Medical Oncology
[3] Biotheranostics Inc,undefined
[4] A Hologic Company,undefined
来源：
BMC Cancer | / 23卷
关键词：
Breast Cancer Index; Extended adjuvant endocrine therapy; Endocrine therapy adherence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Safety of adjuvant endocrine therapies in hormone receptor-positive early breast cancer
    Sehdev, S.
    Martin, G.
    Sideris, L.
    Lam, W.
    Brisson, S.
    CURRENT ONCOLOGY, 2009, 16 : S16 - S25
  • [22] Adjuvant treatment in hormone receptor-positive early breast cancer: New approaches of endocrine therapy
    Nardin, Simone
    Ruelle, Tommaso
    Giannubilo, Irene
    Del Mastro, Lucia
    TUMORI JOURNAL, 2024, 110 (03): : 162 - 167
  • [23] Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer
    Hu, Xin
    Walker, Mark S.
    Stepanski, Edward
    Kaplan, Cameron M.
    Martin, Michelle Y.
    Vidal, Gregory A.
    Schwartzberg, Lee S.
    Graetz, Ilana
    JAMA NETWORK OPEN, 2022, 5 (08) : E2225485
  • [24] Survival Outcomes of Early-Stage Hormone Receptor-Positive Breast Cancer in Elderly Women
    Nayyar, Apoorve
    Strassle, Paula D.
    Iles, Kathleen
    Jameison, Danielle
    Jadi, Jihane
    McGuire, Kandace P.
    Gallagher, Kristalyn K.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (12) : 4853 - 4860
  • [25] Survival Outcomes of Early-Stage Hormone Receptor-Positive Breast Cancer in Elderly Women
    Apoorve Nayyar
    Paula D. Strassle
    Kathleen Iles
    Danielle Jameison
    Jihane Jadi
    Kandace P. McGuire
    Kristalyn K. Gallagher
    Annals of Surgical Oncology, 2020, 27 : 4853 - 4860
  • [26] Prolonged endocrine therapy in the management of hormone receptor-positive early-stage breast cancer: What is the appropriate duration?
    Micha, John P. P.
    Rettenmaier, Mark A. A.
    Bohart, Randy D. D.
    Goldstein, Bram H. H.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2023, 49 (04) : 1079 - 1082
  • [27] Checkpoint inhibition for early-stage hormone receptor-positive breast cancer
    Schlam, Ilana
    Corti, Chiara
    Sammons, Sarah
    Mittendorf, Elizabeth A.
    Tolaney, Sara M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (06) : 511 - 520
  • [28] EXTENDED ADJUVANT ENDOCRINE THERAPY IN HORMONE-RECEPTOR POSITIVE BREAST CANCER
    Goss, P. E.
    Badovinac-Crnjevic, T.
    Fan, L.
    BREAST, 2013, 22 : S18 - S18
  • [29] Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer
    Strasser-Weippl, Kathrin
    Badovinac-Crnjevic, Tanja
    Fan, Lei
    Goss, Paul E.
    BREAST, 2013, 22 : S171 - S175
  • [30] Suboptimal adherence to adjuvant endocrine therapy (ET) in Brazilian women with early-stage estrogen receptor-positive (ER plus ) breast cancer
    Assad-Suzuki, Daniele
    Resende, Heloisa
    Santos, Danielle
    Moura, Fernanda
    Oliveira, Sulene
    Shimada, Andrea
    Galvao, Anna Luiza
    Souza, Bruno
    Castro, Amanda
    Andrade, Monalisa
    Beckedorff, Yuri
    Magalhaes, Maria Cristina
    Souza, Cristiano
    Paiva, Carlos
    Pereira, Daniela
    Rodrigues, Angelica
    Rosa, Daniela
    Barroso-Sousa, Romualdo
    CANCER RESEARCH, 2024, 84 (09)
12345